Pancreatic Cancer Research

ResearcherUniversity of Oklahoma Health Sciences CenterActive in the last 2 years

Zhijun Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2226-2223; OpenAlex author ID A5051324146. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
57
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 3 papers · 2022: 4 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 14

  1. Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-5716↗
  2. ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16. Co-author DOI 10.1172/jci195970↗
  3. The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia. Co-author DOI 10.1016/j.ccell.2024.03.009↗
  4. Replication stress identifies novel molecular classification associated with treatment outcomes in pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.11.008↗
  5. Pancreatic Cancer: Targeted Therapy Holds the Promise. Co-author DOI 10.1016/j.ebiom.2021.103755↗
  6. Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition. Co-author DOI 10.1016/j.ebiom.2022.104352↗
  7. Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2-AKT-TGF-β Signaling Axis in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2022.02.017↗
  8. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2022.06.058↗
  9. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2021.103271↗
  10. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2020.12.077↗
  11. MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-0414↗
  12. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancrea… Co-author DOI 10.1053/j.gastro.2019.10.038↗
  13. Tuft Cells Play Critical Roles in the Heterogeneity and Epithelial Plasticity in Pancreatic Cancer Initiation and Progression. First author DOI 10.1053/j.gastro.2020.09.004↗
  14. ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism. Co-author DOI 10.1158/1078-0432.ccr-18-0263↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Li · 10 shared papers, 2020–2026 · strength 1.74
  2. Courtney W. Houchen · 10 shared papers, 2018–2026 · strength 1.51
  3. Jingxuan Yang · 9 shared papers, 2018–2024 · strength 1.05
  4. Xiuhui Shi · 7 shared papers, 2021–2024 · strength 0.90
  5. Mingyang Liu · 7 shared papers, 2018–2024 · strength 0.86
  6. Shaobo Zhang · 2 shared papers, 2025–2026 · strength 0.49
  7. Haoran Qi · 2 shared papers, 2025–2026 · strength 0.49
  8. Hanxiang Zhan · 3 shared papers, 2020–2021 · strength 0.30
  9. Mingyang Liu · 1 shared paper, 2026 · strength 0.26
  10. Hao Yuan · 1 shared paper, 2026 · strength 0.26
  11. Lei Zheng · 2 shared papers, 2018–2024 · strength 0.23
  12. Yumeng Hu · 1 shared paper, 2025 · strength 0.22
  13. Mingyang Liu · 1 shared paper, 2025 · strength 0.22
  14. Fangxia Wang · 1 shared paper, 2025 · strength 0.22
  15. Min Li · 1 shared paper, 2025 · strength 0.22
  16. Wenming Wu · 1 shared paper, 2025 · strength 0.22
  17. Alex Arreola · 1 shared paper, 2024 · strength 0.17
  18. Ryan David Nipp · 1 shared paper, 2024 · strength 0.17
  19. Landon L. Moore · 1 shared paper, 2020 · strength 0.16
  20. Xiaobo Cui · 2 shared papers, 2018–2020 · strength 0.15
  21. Martín E. Fernández-Zapico · 2 shared papers, 2018–2020 · strength 0.15
  22. Yuqing Zhang · 1 shared paper, 2022 · strength 0.12
  23. Shutao Pan · 1 shared paper, 2022 · strength 0.12
  24. Yan Zhao · 1 shared paper, 2022 · strength 0.12
  25. Xingjun Guo · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.